Skip to content

Right Ventricular Clearance Index (RVCI): A Simple New Parameter To Assess The Right Ventricular Systolic Function Using Contrast Echocardiography In Critically Ill Patients

Right Ventricular Clearance Index (RVCI): A Simple New Parameter To Assess The Right Ventricular Systolic Function Using Contrast Echocardiography In Critically Ill Patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12613001339741
Enrollment
35
Registered
2013-12-09
Start date
2013-12-02
Completion date
2014-01-15
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The aims of this trial are to study the correlation between right ventricular clearance index(RVCI) and two classical echocardiographic parameters of the right ventricular systolic function: TAPSE and S’ and to test the ability of RVCI to predict right ventricular systolic dysfunction.

Interventions

Patients undergo both transthoracic and transesophageal echocardiography performed by an experienced operator. The approximate duration of examination is 30 minutes. Both the transthoracic and transesophageal echocardiography are undertaken only one occasion. During transthoracic echocardiography, we measure TAPSE (tricuspid annular plane systolic excurtion), S' (tricuspid annular plane systolic peak velocity), and PASP (pulmonary artery systolic pressure). During the transesophageal echocard

Patients undergo both transthoracic and transesophageal echocardiography performed by an experienced operator. The approximate duration of examination is 30 minutes. Both the transthoracic and transesophageal echocardiography are undertaken only one occasion. During transthoracic echocardiography, we measure TAPSE (tricuspid annular plane systolic excurtion), S' (tricuspid annular plane systolic peak velocity), and PASP (pulmonary artery systolic pressure). During the transesophageal echocardiography, we perform a contrast test by injecting 5 ml of ultrasound contrast agent as a bolus through the central venous catheter. The time taken by the contrast agent to totally disappear from the right ventricular is called T and is noted in seconds. The right ventricular clearance index (RVCI) is defined as follows: RVCI= (T/HR)*100 (HR = heart rate). The right atrial pressure (RAP) is measured using the central venous catheter. We will test correlations between RVCI, TAPSE and S'. We will also test correlations between RVCI, PASP and RAP We will study the ability of RVCI to detect right ventricular systolic dysfunction defined with TAPSE<16mm or S'<10cm/s

Sponsors

Military Hospital Of Tunis
Lead SponsorHospital

Study design

Allocation
Non-randomised trial
Primary purpose
Diagnosis

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1 Critically ill patients 2 Sedated 3 Invasively ventilated 4 With preexisting internal jugular or subclavian central venous catheter

Exclusion criteria

1 Transthoracic echocardiography images with poor quality 2 Contraindication to transesophageal echocardiography 3 Impossibility to introduce the transesophageal echocardiography probe 4 If the central venous catheter tip was not in the right atrium 5 Evidence of intracardiac shunt 6 Organic tricuspid regurgitation 7 Surgical procedure on the tricuspid valve

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026